Aviceda Therapeutics Completes Enrollment of Phase 2b SIGLEC Study Assessing the Safety and Efficacy of AVD-104 for Geographic Atrophy Secondary to AMDBusiness Wire • 09/24/24
If You'd Invested $10,000 in AMD Stock 10 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 09/19/24
Advanced Micro Devices (AMD) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 09/18/24
The Zacks Analyst Blog Bank of America, Advanced Micro Devices, Linde, Comstock and KingswayZacks Investment Research • 09/17/24
Why AI Chip Stocks Advanced Micro Devices, Arm Holdings, and Marvell Technologies Rallied This WeekThe Motley Fool • 09/13/24